Safety and Tolerability of BI 409306 in Patients With Schizophrenia
Clinical trial NCT01892384 · COMPLETED
Trial details
- NCT number
- NCT01892384
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-28
- Primary completion
- 2013-12-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.